HANDBOOK ON INJECTABLE DRUGS (H/C) (REVISED EDITION)

IN THE EVER-CHANGING, DATA-INTENSE, SPLIT-SECOND DECISION WORLD OF PARENTERAL DRUGS, THAT TOUCHSTONE, THAT PREMIER RESOURCE, IS THE HANDBOOK ON INJECTABLE DRUGS, 16TH EDITION. IT IS THE LEADING INJECTABLE DRUG GUIDE, TRUSTED, TURNED TO AND TOUTED THE WORLD OVER FOR ITS INTUITIVE, EASY TO USE LAYOUT AND ITS ACCESSIBLE ORGANIZATION AND PRESENTATION OF DATA. THE HANDBOOK PRESENTS 349 PARENTERAL DRUGS COMMERCIALLY AVAILABLE IN THE UNITED STATES AND ELSEWHERE IN ALPHABETICAL ORDER BY NONPROPRIETARY NAME, INCLUDING BRAND NAMES FOR ABSOLUTE USEFULNESS AND CLARITY. REFERENCES CAN BE QUICKLY CROSS-REFERENCED USING THE AHFS CLASSIFICATION SYSTEM. IN THE 16TH EDITION, ALL THE MONOGRAPHS ARE UPDATED, WITH 349 IN ALL, INCLUDING NEW PARENTERAL DRUGS NOT COVERED IN THE PREVIOUS VOLUME. THEY ARE DORIPENEM, SOMEPRAZOLE SODIUM, IBUPROFEN LYSINE, INSULIN LISPRO, HYDROXYETHYLSTARCH 130/0.4 IN SODIUM CHLORIDE 0.9%, AND MOXIFLOXACIN HCL. COMPATIBILITY, STABILITY, STORAGE AND PREPARATION DATA FOR EACH HAVE